Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Qianyuan Li
PARP Inhibitor Re‑sensitizes Adriamycin Resistant Leukemia Cells Through DNA Damage and Apoptosis
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Related publications
PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Brca2Deficiency Sensitizes Cells to PARP Inhibition
Cancer Research
Cancer Research
Oncology
The NEDD8-activating Enzyme Inhibitor MLN4924 Induces DNA Damage in Ph+ Leukemia and Sensitizes for ABL Kinase Inhibitors
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
mTORC1/2 Inhibition Re-Sensitizes Platinum-Resistant Ovarian Cancer by Disrupting Selective Translation of DNA Damage and Survival mRNAs
Oncotarget
Oncology
PARP Inhibitor Veliparib and HDAC Inhibitor SAHA Synergistically Co-Target the UHRF1/BRCA1 DNA Damage Repair Complex in Prostate Cancer Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
EZH2 Inhibition Re-Sensitizes Multidrug Resistant B-Cell Lymphomas to Etoposide Mediated Apoptosis
Oncoscience
Cancer Research
Oncology
Loss of Urokinase Receptor Sensitizes Cells to DNA Damage and Delays DNA Repair
PLoS ONE
Multidisciplinary
Regulation of DNA Damage Response and Cell Cycle in Radiation-Resistant HL60 Myeloid Leukemia Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Zoledronic Acid Overcomes Adriamycin Resistance in Acute Myeloid Leukemia Cells by Promoting Apoptosis
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
